Michel Vallée
Université de Montréal(CA)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Parathyroid Disorders and Treatments, Dialysis and Renal Disease Management, Sodium Intake and Health, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension(2015)694 cited
- → Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children(2018)578 cited
- → Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children(2020)575 cited
- → Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension(2016)468 cited
- → The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy(2010)374 cited
- → The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – blood pressure measurement, diagnosis and assessment of risk(2010)347 cited
- → Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults(2017)321 cited
- → The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension(2014)270 cited
- → The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy(2012)266 cited
- → Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial(2022)211 cited